- Home
- HTBK vs MGTX Comparison
HTBK vs MGTX Comparison
Compare HTBK & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTBK
- MGTX
- Stock Information
- Founded
- HTBK 1997
- MGTX 2015
- Country
- HTBK United States
- MGTX United States
- Employees
- HTBK N/A
- MGTX N/A
- Industry
- HTBK Major Banks
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTBK Finance
- MGTX Health Care
- Exchange
- HTBK Nasdaq
- MGTX Nasdaq
- Market Cap
- HTBK 566.4M
- MGTX 479.9M
- IPO Year
- HTBK 1998
- MGTX N/A
- Fundamental
- Price
- HTBK $10.50
- MGTX $7.30
- Analyst Decision
- HTBK Buy
- MGTX Strong Buy
- Analyst Count
- HTBK 3
- MGTX 2
- Target Price
- HTBK $11.50
- MGTX $23.50
- AVG Volume (30 Days)
- HTBK 450.4K
- MGTX 257.4K
- Earning Date
- HTBK 01-23-2025
- MGTX 03-13-2025
- Dividend Yield
- HTBK 4.80%
- MGTX N/A
- EPS Growth
- HTBK N/A
- MGTX N/A
- EPS
- HTBK 0.66
- MGTX N/A
- Revenue
- HTBK $170,257,000.00
- MGTX $13,929,000.00
- Revenue This Year
- HTBK N/A
- MGTX N/A
- Revenue Next Year
- HTBK $5.03
- MGTX $1,391.84
- P/E Ratio
- HTBK $16.29
- MGTX N/A
- Revenue Growth
- HTBK N/A
- MGTX 108.24
- 52 Week Low
- HTBK $7.66
- MGTX $3.85
- 52 Week High
- HTBK $11.27
- MGTX $7.80
- Technical
- Relative Strength Index (RSI)
- HTBK 62.99
- MGTX 66.58
- Support Level
- HTBK $10.30
- MGTX $6.72
- Resistance Level
- HTBK $10.79
- MGTX $7.06
- Average True Range (ATR)
- HTBK 0.34
- MGTX 0.37
- MACD
- HTBK 0.05
- MGTX 0.05
- Stochastic Oscillator
- HTBK 76.16
- MGTX 71.61
About HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two segments, namely Banking and Factoring. The bank generates its revenue from the Banking segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.